These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 15127368

  • 1. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C.
    J Lab Clin Med; 2004 May 15; 143(5):269-83. PubMed ID: 15122171
    [Abstract] [Full Text] [Related]

  • 3. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr 15; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

  • 4. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
    Peterson LR.
    Clin Infect Dis; 2006 Jan 15; 42(2):224-33. PubMed ID: 16355333
    [Abstract] [Full Text] [Related]

  • 5. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J, Ewig S, Kresken M.
    Pneumologie; 2002 Oct 15; 56(10):605-9. PubMed ID: 12375222
    [Abstract] [Full Text] [Related]

  • 6. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
    Nuermberger E, Bishai WR.
    Clin Infect Dis; 2004 Jan 01; 38(1):99-103. PubMed ID: 14679455
    [Abstract] [Full Text] [Related]

  • 7. Clinical impact of antibiotic resistance in respiratory tract infections.
    Klugman KP.
    Int J Antimicrob Agents; 2007 Feb 01; 29 Suppl 1():S6-10. PubMed ID: 17307654
    [Abstract] [Full Text] [Related]

  • 8. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ, Jenkins SG.
    J Antimicrob Chemother; 2004 Aug 01; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.
    Lynch III JP, Martinez FJ.
    Clin Infect Dis; 2002 Mar 01; 34 Suppl 1():S27-46. PubMed ID: 11810608
    [Abstract] [Full Text] [Related]

  • 10. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC.
    Clin Infect Dis; 2000 Aug 01; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN, Fritsche TR, Sader HS.
    Diagn Microbiol Infect Dis; 2005 Jun 01; 52(2):129-33. PubMed ID: 15964501
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T, Asian Network for Surveillance of Resistant Pathogens Study Group.
    Clin Infect Dis; 2004 Jun 01; 38(11):1570-8. PubMed ID: 15156445
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
    Chiba N, Kobayashi R, Hasegawa K, Morozumi M, Nakayama E, Tajima T, Iwata S, Ubukata K, Acute Respiratory Diseases Study Group.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):756-60. PubMed ID: 16131518
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
    Fogarty C, Torres A, Choudhri S, Haverstock D, Herrington J, Ambler J.
    Int J Clin Pract; 2005 Nov 01; 59(11):1253-9. PubMed ID: 16236076
    [Abstract] [Full Text] [Related]

  • 15. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P, Finnish Study Group for Antimicrobial Resistance (FiRe-Network).
    Clin Infect Dis; 2001 Aug 15; 33(4):483-8. PubMed ID: 11462184
    [Abstract] [Full Text] [Related]

  • 16. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML, Australian CAP Study Collaboration.
    Clin Infect Dis; 2008 May 15; 46(10):1513-21. PubMed ID: 18419484
    [Abstract] [Full Text] [Related]

  • 17. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN, Sader HS, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 May 15; 58(1):1-7. PubMed ID: 17408904
    [Abstract] [Full Text] [Related]

  • 18. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M, Huikko S, Huovinen P, Paakkari P, Seppälä H, Finnish Study Group for Antimicrobial Resistance (FiRe Network).
    Antimicrob Agents Chemother; 2006 Nov 15; 50(11):3646-50. PubMed ID: 16940064
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ, Zhanel GG.
    Expert Rev Anti Infect Ther; 2006 Dec 15; 4(6):973-80. PubMed ID: 17181414
    [Abstract] [Full Text] [Related]

  • 20. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
    Rzeszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG.
    Int J Antimicrob Agents; 2004 Aug 15; 24(2):95-104. PubMed ID: 15288306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.